Risk for Postpartum CVD Readmissions Higher for Twin Pregnancies

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 10, 2025.

By Elana Gotkine HealthDay Reporter

MONDAY, Feb. 10, 2025 -- Twin pregnancies have increased risks for cardiovascular disease (CVD) readmissions in the first year postpartum, even in the absence of hypertensive disorders of pregnancy (HDP), according to a study published online Feb. 3 in the European Heart Journal.

Ruby Lin, M.D., from Rutgers Robert Wood Johnson Medical School in New Brunswick, New Jersey, and colleagues estimated the rates of CVD readmission in twin deliveries with and without HDP and singleton deliveries with and without HDP using the Nationwide Readmissions Database of U.S. hospitals from 2010 to 2020.

The researchers found that the rates of CVD readmission in twin and singleton pregnancies were 1,105.4 and 734.1 per 100,000 delivery admissions, respectively, among 36 million delivery hospitalizations. Compared with singleton pregnancies without HDP, the adjusted hazard ratios for CVD readmissions were highest for twin pregnancies with HDP, followed by singleton pregnancies with HDP and twin pregnancies without HDP (hazard ratios, 8.21, 5.89, and 1.95, respectively).

"Our findings of increased heart disease and stroke in patients with twin pregnancies up to 12 months postdelivery should not be discounted despite the previous research showing no long-term increase in cardiovascular morbidity or mortality for twin pregnancies, given maternal mortality is associated with CVD," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-02-11 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords